Document is current
Any future updates will be listed below
-
Authors
Salinger, Allison P.
Vermes, Ellen
Waid, Jillian L.
Wendt, Amanda S.
Dupuis, Sarah J. N.
Kalam, Md Abul
Kader, Abdul
Sinharoy, Sheela S.
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-008977, INV-008977, INV-008977, INV-008977, INV-008977, INV-008977)
United States Agency for International Development (EEM-G-00-04-00013-00, EEM-G-00-04-00013-00, EEM-G-00-04-00013-00, EEM-G-00-04-00013-00, EEM-G-00-04-00013-00, EEM-G-00-04-00013-00)
Bundesministerium für Bildung und Forschung (01ER1201, 01ER1201, 01ER1201, 01ER1201, 01ER1201, 01ER1201)
- License Information
-
More Information
Article History
Received: 17 July 2023
Accepted: 3 January 2024
First Online: 1 February 2024
Declarations
:
: The data analysed in this study were collected in accordance with relevant guidelines and regulations as part of the FAARM trial (ClinicalTrials.gov: NCT02505711). The study protocol was positively reviewed and approved by the ethics committees of the James P Grant School of Public Health at BRAC University in Bangladesh and Heidelberg University in Germany. FAARM is registered with ClinicalTrials.gov (NCT02505711). All study participants gave written informed consent at the trial baseline. All documents were read out loud to participants who were then able to ask questions. If the respondent was illiterate, written consent was given by thumbprint and the signature of an independent witness (i.e., a subject that is not part of the study team). This analysis used deidentified data.
: Not applicable.
: The authors declare no competing interests.
